fda glp-1 safety warning september 2025 Targets and Peptide Compounding, Advertising and 'Research Use Only' Labeling GLP-1 drugs are all approved

Nutritional interventions, especially increased protein intake, may offer protective effects against muscle loss, though GLP-1 RAs therapies may inadvertently suppress protein-rich food consumption

For people living with overweight or obesity, the experience tends to be even stronger many people said their relationship with food feels uncontrollable, and nearly 70% said it directly harms their mental health

If spontaneous desire has decreased on semaglutide, creating intentional opportunities for physical connection can activate the responsive desire system

Published online March 2004:848-851

B.MunteanuM.DotsenkoS.NiemoellerE.BokaG.WuY.et al (2014)

Professor De Cristofaro, Dr